| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |